assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001611975.1_ASM161197v1	NZ_CP014527	Haematospirillum jordaniae strain H5569 plasmid unnamed 2, complete sequence	1	151177-151605	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas2,cas1,cas9	c2c9_V-U4,cas2,cas1,cas9	 Type II-B,Type II-B,Type II-C, or Type II-C?,Type II-A	GTTGCTGCTTGACCGCAATTTCTGAGATGCTAGTCT,GTTGCTGCTTGACCGCAATTTCTGAGATGCTAGTCT,GTTGCTGCTTGACCGCAATTTCTGAGATGCTAGTCT	36,36,36	2	2	151409-151438|151541-151569	NZ_CP014525.1_1392903-1392932|NZ_CP014525.1_1394050-1394022	NA:NA:NA	6,6,6	6	TypeII-B,TypeII-B,TypeII-C,orTypeII-C?,TypeII-A	csa3,c2c9_V-U4,DEDDh,DinG,cas2,cas1,cas9	NA|158aa|up_4|NZ_CP014527.1_141114_141588_-,NA|93aa|down_8|NZ_CP014527.1_165522_165801_+	NA|96aa|up_9|NZ_CP014527.1_137406_137694_+	cd14737, PAAR_1, proline-alanine-alanine-arginine (PAAR) domain	NA|113aa|up_8|NZ_CP014527.1_137753_138092_+	PHA02516, W, baseplate wedge subunit; Provisional	NA|299aa|up_7|NZ_CP014527.1_138091_138988_+	PHA02568, J, baseplate assembly protein; Provisional	NA|233aa|up_6|NZ_CP014527.1_138980_139679_+	COG4385, gpI, Bacteriophage P2-related tail formation protein [General function prediction only]	NA|59aa|up_5|NZ_CP014527.1_139711_139888_+	pfam12571, DUF3751, Phage tail-collar fibre protein	NA|158aa|up_4|NZ_CP014527.1_141114_141588_-	NA	NA|1826aa|up_3|NZ_CP014527.1_141584_147062_-	pfam05860, Haemagg_act, haemagglutination activity domain	NA|139aa|up_2|NZ_CP014527.1_147321_147738_-	COG2831, FhaC, Hemolysin activation/secretion protein [Intracellular trafficking and secretion]	NA|330aa|up_1|NZ_CP014527.1_147780_148770_-	COG2831, FhaC, Hemolysin activation/secretion protein [Intracellular trafficking and secretion]	NA|216aa|up_0|NZ_CP014527.1_150487_151135_-	pfam10134, RPA, Replication initiator protein A	cas2|102aa|down_0|NZ_CP014527.1_151679_151985_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|304aa|down_1|NZ_CP014527.1_152020_152932_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|1062aa|down_2|NZ_CP014527.1_152991_156177_-	COG3513, COG3513, Predicted CRISPR-associated nuclease, contains McrA/HNH-nuclease and RuvC-like nuclease domain [Defense mechanisms]	NA|73aa|down_3|NZ_CP014527.1_156658_156877_-	pfam09386, ParD, Antitoxin ParD	NA|1156aa|down_4|NZ_CP014527.1_157803_161271_+	NF033203, entero_EhxA, enterohemolysin EhxA	NA|479aa|down_5|NZ_CP014527.1_161594_163031_+	NF033203, entero_EhxA, enterohemolysin EhxA	NA|397aa|down_6|NZ_CP014527.1_163322_164513_+	NF033203, entero_EhxA, enterohemolysin EhxA	NA|227aa|down_7|NZ_CP014527.1_164839_165520_+	PHA02518, PHA02518, ParA-like protein; Provisional	NA|93aa|down_8|NZ_CP014527.1_165522_165801_+	NA	NA|571aa|down_9|NZ_CP014527.1_166264_167977_-	smart00857, Resolvase, Resolvase, N terminal domain
